About: Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine
Creator	Seale, Holly Heywood, Anita Van, Debbie Ward, Kirsten Lowbridge, Chris Mclaws, Mary-Louise Raina Macintyre, C
topic	covid:8e67618920b0226e661e20a2c36b4436857d9590#this
source	Medline; PMC
abstract	BACKGROUND: On the 30th September 2009, the pandemic (H1N1) 2009 influenza vaccine was made available to adults and children aged 10 years and over, in Australia. Acceptance of a novel vaccine is influenced by perceptions of risk including risk of infection, risk of death or severe illness and risk of serious vaccine side-effects. We surveyed a sample of residents from Sydney, Australia to ascertain their risk perception, attitudes towards the pandemic and willingness to accept the pandemic (H1N1) 2009 influenza vaccine. METHODS: We sampled residents using a cross-sectional intercept design during the WHO Phase 6. Members of the public were approached in shopping and pedestrian malls to undertake the survey during September and October 2009. The survey measured perceived risk, seriousness of disease, recent behavioural changes, likely acceptance of the pandemic (H1N1) 2009 vaccine and issues relating to uptake and perceived safety. RESULTS: Of the 627 respondents, the majority felt that they had a %22very low to low%22 (332/627, 52.9%) risk of acquiring H1N1. 24.5% (154/627) of respondents believed that the disease would %22very seriously or extremely%22 affect their health. Nearly half (305/627, 48.6%) reported that in response to the %22swine flu%22 outbreak they had undertaken one or more of the investigated behavioural changes. Overall, the self-reported likelihood of accepting vaccination against novel H1N1 was 54.7% (343/627). CONCLUSIONS: While, most participants did not believe they were at high risk of acquiring pandemic H1N1 2009, over half of the sample indicated that they would accept the vaccine. Participants who were vaccinated against the seasonal influenza were more likely to receive the H1N1 vaccine. Concerns about safety, the possibility of side effects and the vaccine development process need to be addressed.
has issue date	2010-04-19(xsd:dateTime)
bibo:doi	10.1186/1471-2334-10-99
bibo:pmid	20403201
has license	cc-by
sha1sum (hex)	8e67618920b0226e661e20a2c36b4436857d9590
schema:url	https://doi.org/10.1186/1471-2334-10-99
resource representing a document's title	Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine
has PubMed Central identifier	PMC2864274
has PubMed identifier	20403201
schema:publication	BMC Infect Dis
resource representing a document's body	covid:8e67618920b0226e661e20a2c36b4436857d9590#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/8e67618920b0226e661e20a2c36b4436857d9590
is schema:about of	named entity 'aged' named entity 'Australia' named entity 'Acceptance' named entity 'YEARS' named entity 'DEATH' named entity 'ACCEPTANCE' named entity 'OF RISK' named entity 'VACCINE' named entity 'RISK OF' named entity 'ATTITUDES' named entity 'CHILDREN' named entity 'ADULTS' named entity 'SAMPLE' named entity 'AVAILABLE' named entity 'ACCEPT' named entity 'RISK PERCEPTION' named entity 'SEVERE' named entity 'PANDEMIC' named entity 'ILLNESS' named entity 'EFFECTS' named entity 'PANDEMIC' named entity 'AUSTRALIA' named entity 'BACKGROUND' named entity 'AT RISK' named entity 'NEED' named entity 'VACCINE' named entity 'THEIR' named entity 'WHY' named entity 'RISK OF INFECTION' named entity 'SEPTEMBER' named entity 'NOVEL' named entity 'PERCEPTIONS' named entity 'AGED' named entity 'PUBLIC' named entity 'INFLUENZA VACCINE' named entity 'INCLUDING' named entity 'PERCEPTIONS' named entity 'SYDNEY' named entity 'adults' named entity 'H1N1' named entity 'influenza vaccine' named entity 'side-effects' named entity 'Sydney' named entity 'infection' named entity 'September' named entity '2009' named entity 'influenced' named entity 'pandemic' named entity 'infection' named entity 'perceptions of risk' named entity 'risk of death' named entity 'H1N1' named entity 'Australia' named entity 'influenza vaccine' named entity 'vaccination' named entity 'vaccine' named entity 'influenza' named entity 'H1N1 vaccine' named entity 'Sydney' named entity 'chronic respiratory disease' named entity 'pathogen' named entity 'vaccine' named entity 'H1N1' named entity 'Sydney' named entity 'Argentina' named entity 'influenza vaccine' named entity 'influenza vaccine' named entity 'H1N1' named entity 'pandemic influenza' named entity 'vaccination' named entity 'influenza vaccine' named entity 'seasonal influenza' named entity 'H1N1 vaccine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software